CryJ2-DNA-LAMP plasmid

· Immunomic Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CryJ2-DNA-LAMP plasmid, covering 2014-04-30 to 2014-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid [Phase 1]

See pricing